Link Details
- Metabolite
- HMDB0000122 (D-Glucose)
- DrugBank ID
- DB01200
- Drug Name
- Bromocriptine
- Effect
- Decrease
- Biospecimen
- Blood
- P-value
- Not Available
- Beta Estimator
- Not Available
- Percent Change
- Not Available
- Pearson Correlation Coefficient
- Not Available
- Comments
- Not Available
- Keche Y: Bromocriptine mesylate: Food and Drug Administration approved new approach in therapy of non-insulin dependant diabetes mellitus with poor glycemic control. J Pharm Bioallied Sci. 2010 Apr;2(2):148-50. doi: 10.4103/0975-7406.67000. [PubMed:21814451 ]
- Cincotta AH, Meier AH, Cincotta Jr M: Bromocriptine improves glycaemic control and serum lipid profile in obese Type 2 diabetic subjects: a new approach in the treatment of diabetes. Expert Opin Investig Drugs. 1999 Oct;8(10):1683-1707. [PubMed:11139820 ]
- Defronzo RA: Bromocriptine: a sympatholytic, d2-dopamine agonist for the treatment of type 2 diabetes. Diabetes Care. 2011 Apr;34(4):789-94. doi: 10.2337/dc11-0064. [PubMed:21447659 ]